12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

Weisdorf, D. J., Anasetti, C., Antin, J. H., Kernan, N. A., Kollman, C., Snyder, D., Petersdorf, E., Nelson, G., and
McGlave, P. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of
unrelated versus matched sibling donor transplantation. Blood, 99: 1971-1977, 2002.Or, R., Shapira, M. Y.,
Resnick, I., Amar, A., Ackerstein, A., Samuel, S., Aker, M., Naparstek, E., Nagler, A., and Slavin, S.
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first
chronic phase. Blood, 2002.
Mini-HCT
Or,R., Shapira,M.Y., Resnick,I., Amar,A., Ackerstein,A., Samuel,S., Aker,M., Naparstek,E., Nagler,A., &
Slavin,S. (2003) Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid
leukemia in first chronic phase. Blood, 101, 441-445.
Sloand,E., Childs,R.W., Solomon,S., Greene,A., Young,N.S., & Barrett,A.J. (2003) The graft-versus-leukemia
effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. Bone
Marrow Transplant., 32, 897-901.
Crawley,C., Szydlo,R., Lalancette,M., Bacigalupo,A., Lange,A., Brune,M., Juliusson,G., Nagler,A., Gratwohl,A.,
Passweg,J., Komarnicki,M., Vitek,A., Mayer,J., Zander,A., Sierra,J., Rambaldi,A., Ringden,O., Niederwieser,D.,
& Apperley,J.F. (2005) Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis
of prognostic factors from the Chronic Leukemia Working Party of the EBMT. Blood, 106, 2969-2976.
Kerbauy,F.R., Storb,R., Hegenbart,U., Gooley,T., Shizuru,J., Al Ali,H.K., Radich,J.P., Maloney,D.G., Agura,E.,
Bruno,B., Epner,E.M., Chauncey,T.R., Blume,K.G., Niederwieser,D., & Sandmaier,B.M. (2005) Hematopoietic
cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of
CML. Leukemia, 19, 990-997.
58